Where Should a Healthcare Provider Grow Next? A TAM/SAM/SOM Approach to Choosing Your Next Market

Direct answer: Healthcare providers should choose their next growth market by sizing it in three layers — the total addressable population and spend (TAM), the portion your service lines and licensure can realistically serve (SAM), and the share you can actually capture given payer contracts, referral networks, and capacity (SOM). The mistake most systems make is anchoring on TAM headlines ("a $50B market") instead of the SOM reality, which is constrained by things like network adequacy, credentialing timelines, and local competition. Growth decisions get sharper when you start from what you can win, not what exists.

Why TAM/SAM/SOM fits healthcare growth decisions

Healthcare growth questions are rarely "is there demand?" — demand for care is nearly infinite. The real questions are: Where is unmet, reimbursable demand? and Can we serve it profitably given our constraints? TAM/SAM/SOM forces those distinctions.

• TAM (Total Addressable Market): The entire population and associated healthcare spend for a service, in a defined geography, regardless of whether you can serve them.
• SAM (Serviceable Addressable Market): The slice of TAM your organization is licensed, staffed, and contracted to serve — filtered by service line, payer mix, and regulatory scope.
• SOM (Serviceable Obtainable Market): The realistic share you can capture in a defined window, given competition, referral relationships, capacity, and payer negotiating position.

For a provider, the gap between SAM and SOM is usually where strategy lives. That gap is defined by referral control, network status, and physical or virtual capacity — not by how many people are sick.

A concrete walkthrough: sizing a new service line or location

Say you run a multi-specialty group evaluating whether to expand orthopedics into an adjacent county.

Step 1 — Define the TAM. Ask: What is the addressable population, and what do they spend on this service?

• Population of the target geography.
• Prevalence or utilization rate for the condition/procedure (from payer data, CMS datasets, or specialty registries — use real sources, not guesses).
• Average reimbursement per episode. Multiply population × utilization × price = TAM. Good practice: build TAM from the bottom up (procedures × price) rather than top-down ("X% of a national number").

Step 2 — Narrow to SAM. Ask: Which of that demand can we legally and operationally serve?

• Which payers do you contract with, and what's their local membership share?
• Does your licensure and credentialing cover the target county?
• Do you have (or can you recruit) the specialists needed? SAM is TAM filtered by payer mix and service scope. A large TAM with a payer you don't contract with is not your market.

Step 3 — Estimate SOM. Ask: What share can we actually take, and from whom?

• Who are the incumbent providers, and how sticky are their referral relationships?
• What is realistic capacity in year one, two, three?
• What is your differentiation — access times, outcomes, site-of-care cost? SOM is best expressed as a ramp, not a single number: a defensible year-one capture rate that grows as referral relationships and reputation build.

What "good" looks like: Each layer is traceable to a source. Your SOM assumptions are conservative and tied to concrete mechanisms (a signed payer contract, a recruited surgeon, a referral agreement) — not optimism. And the analysis compares at least two or three candidate markets so growth is a choice, not a rationalization.

Where Percision helps — and where it doesn't

Disclosure: I write for Percision, the strategic intelligence platform behind this blog, so treat this as one option among several.

Percision is useful when you're evaluating multiple growth candidates under time pressure and want structured, comparable analysis. You feed in your business context — service lines, payer mix, target geographies, capacity — and it runs the reasoning through structured steps across specialist models, producing a TAM/SAM/SOM breakdown, scenario comparisons, and a board-ready deck in roughly 7–15 minutes rather than weeks. It's explicitly a co-pilot, not an autopilot: your leadership team supplies the local knowledge and makes the call. It also produces financial intelligence — DCF on the expansion, downside scenarios, warning signs — so a growth thesis lands with numbers attached.

Where it turns into execution: the output isn't just a market size, it's a comparison across markets plus a KPI dashboard you can track post-launch (referral volume, capture rate, contribution margin).

When you don't need it:

• If you're evaluating one obvious market and already have the payer data in hand, a spreadsheet and an afternoon are enough.
• If the decision hinges on local political and relationship dynamics — a specific hospital partnership, a CON (Certificate of Need) fight, a physician recruitment negotiation — a healthcare-native human consultant who knows that market will beat any general platform.
• If your bottleneck is primary data you don't have (real local utilization and payer share), no tool invents it; get the data first.

The productivity logic behind AI-assisted analysis is real — a widely cited BCG/Harvard field experiment found consultants using GPT-4 completed tasks faster and at higher quality within the tool's competence, but performed worse on tasks outside it. That's the right frame here: use structured AI to accelerate the sizing and scenario work; keep humans in charge of local judgment and data quality.

Turning the analysis into a growth plan

A TAM/SAM/SOM exercise is only worth it if it produces a decision and a scorecard. Convert it into:

1. A ranked shortlist of markets by SOM, not TAM.
2. A gating checklist per market: payer contracts to secure, credentials to file, staff to recruit.
3. A tracked ramp with the year-one SOM as a target and leading indicators (referral pipeline, contract signings) monitored monthly.

Growth that's mapped this way is auditable — you can see why you chose a market and adjust when assumptions break.

If you want to run several candidate markets through a structured TAM/SAM/SOM and get a board-ready comparison quickly, Percision is one way to do it — with your leadership team keeping the final call.

FAQ

Q: What's the most common TAM/SAM/SOM mistake for healthcare providers? Anchoring on TAM. A big total market says nothing about whether you can win it. Payer mix, referral control, and capacity define SOM — that's the number that should drive the decision.

Q: Do I need patient-level data to do this well? You need reliable utilization and payer-share data for the geography (CMS datasets, payer reports, specialty registries). No tool substitutes for that; it makes the analysis faster and more structured, not more accurate than its inputs.

Q: When is a spreadsheet enough instead of a platform? When you're sizing a single, well-understood market with data you already have. Platforms earn their keep when you're comparing multiple markets, running downside scenarios, and need a defensible, board-ready output fast.